公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Huang Y.-T; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 94 | 76 | |
2012 | High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 430 | 381 | |
2020 | High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy | Chang W.-Y.; Chiu Y.-C; Chiu F.-W; Hsu Y.-C; TAI-CHUNG TSENG ; Cheng P.-N; Yang S.-S; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 5 | 5 | |
2017 | High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments | Nien H.-C.; SHIH-JER HSU ; TUNG-HUNG SU ; PO-JEN YANG ; JIN-CHUAN SHEU ; JIN-TOWN WANG ; LU-PING CHOW ; CHI-LING CHEN ; JIA-HORNG KAO ; WEI-SHIUNG YANG | PLoS ONE | 13 | 12 | |
2015 | Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Yang W.-T; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 48 | 43 | |
2015 | Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; Yang W.-T; Tsai C.-S; Kuo S.F.-T; Verbree F.C; TUNG-HUNG SU ; Wang C.-C; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 98 | 84 | |
2017 | Historical epidemiology of hepatitis C virus in select countries-volume 4 | Maaroufi A.; Vince A.; Himatt S.M.; Mohamed R.; Fung J.; Opare-Sem O.; Workneh A.; Njouom R.; Al ghazzawi I.; Abdulla M.; Kaliaskarova K.S.; Owusu-Ofori S.; Abdelmageed M.K.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; DING-SHINN CHEN ; PEI-JER CHEN ; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kamel Y.; JIA-HORNG KAO ; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukšić B.; Malu A.O.; Mateva L.; Mitova R.; Morović M.; Murphy K.; Mustapha B.; Nde H.; Nersesov A.; Ngige E.; Njoya O.; Nonković D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Simonova M.; TUNG-HUNG SU ; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Wani H.U.; Wong V.W.S.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Razavi-Shearer K. | Journal of Viral Hepatitis | 28 | 26 | |
2013 | Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients | Cheng H.-R.; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Yang H.-I.; Chen C.-J.; JIA-HORNG KAO | PLoS ONE | 48 | 305 | |
2012 | Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission | Lin C.-L.; TAI-CHUNG TSENG ; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 1 | 1 | |
2017 | Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; TUNG-HUNG SU ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Oncotarget | 17 | 15 | |
2016 | Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice | Lin W.-H.; Shiou-Hwei Yeh ; KUN-HUEI YEH ; Chen K.-W.; Cheng Y.-W.; TUNG-HUNG SU ; Jao P.; Ni L.-C.; PEI-JER CHEN ; Chen D.-S. | Proceedings of the National Academy of Sciences of the United States of America | 37 | 34 | |
2017 | Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up | Chen H.-Y.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Yang W.-T.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 12 | 9 | |
2020 | Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection | CHIH-YANG HSIAO ; Teng X.; TUNG-HUNG SU ; PO-HUANG LEE ; JIA-HORNG KAO ; KAI-WEN HUANG | Clinics and Research in Hepatology and Gastroenterology | 5 | 6 | |
2021 | Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling | CHIH-YANG HSIAO ; Teng, Xiao; TUNG-HUNG SU ; PO-HUANG LEE ; JIA-HORNG KAO ; KAI-WEN HUANG | Quantitative Imaging in Medicine and Surgery | 4 | 4 | |
2015 | Improving clinical outcomes of chronic hepatitis B virus infection | TUNG-HUNG SU ; JIA-HORNG KAO | Expert review of Gastroenterology and Hepatology | 26 | 23 | |
2023 | Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study) | Hirode, Grishma; Hansen, Bettina E; Chen, Chien-Hung; TUNG-HUNG SU ; Wong, Grace; Seto, Wai-Kay; Van Hees, Stijn; Papatheodoridi, Margarita; Brakenhoff, Sylvia M; Lens, Sabela; Choi, Hannah S J; Chien, Rong-Nan; Feld, Jordan J; Forns, Xavier; Sonneveld, Milan J; Papatheodoridis, George V; Vanwolleghem, Thomas; Yuen, Man-Fung; Chan, Henry L Y; Kao, Jia-Horng; Hsu, Yao-Chun; Cornberg, Markus; Jeng, Wen-Juei; Janssen, Harry L A; JIA-HORNG KAO et al. | The American journal of gastroenterology | 5 | 2 | |
2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang H.-I.; TAI-CHUNG TSENG ; Liu J.; Lee M.-H.; CHUN-JEN LIU ; TUNG-HUNG SU ; Batrla-Utermann R.; Chan H.L.Y.; JIA-HORNG KAO ; Chen C.-J. | Clinical Gastroenterology and Hepatology | 25 | 22 | |
2012 | Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 40 | 39 | |
2012 | Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin | CHEN-HUA LIU ; Liang, Cheng-Chao; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin, Chih-Lin; Yang, Sheng-Shun; TUNG-HUNG SU ; JOU-WEI LIN ; Chen, Jun-Herng; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral therapy | 21 | 22 | |
2021 | Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma | CHIH-HORNG WU ; PO-CHIN LIANG ; TUNG-HUNG SU ; Lin, Ming-Chi; Chang, Yu-Hsuan; TIFFANY TING-FANG SHIH ; JIA-HORNG KAO | Hepatology international | 8 | 7 | |